NCT02779023 (CBT-I) is a NA clinical trial of Cognitive-Behavior Therapy for Insomnia (CBT-I) in Insomnia, sponsored by Walter Reed National Military Medical Center.

Who is sponsoring NCT02779023?

NCT02779023 is sponsored by Walter Reed National Military Medical Center.

What drugs are being tested in NCT02779023?

Interventions in NCT02779023: Cognitive-Behavior Therapy for Insomnia (CBT-I).

What condition does NCT02779023 study?

NCT02779023 studies Insomnia, Cardiovascular Risk Factor.

Is NCT02779023 still recruiting?

NCT02779023 is currently terminated. Last updated 11 September 2018.

Last reviewed 2018-09-11 · How we verify

NCT02779023: CBT-I

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Integrative Cardiac Health Project Cognitive-Behavior Therapy for Insomnia

Terminated NA Last updated 11 September 2018

What this trial tests

NA trial testing Cognitive-Behavior Therapy for Insomnia (CBT-I) in Insomnia in 6 participants. Terminated before completion.

Timeline

29 October 2015

Primary endpoint
11 July 2016

11 July 2016

Quick facts

Lead sponsor	Walter Reed National Military Medical Center
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	6
Start date	29 October 2015
Primary completion	11 July 2016
Estimated completion	11 July 2016
Sites	1 location across United States

Drugs / interventions tested

Cognitive-Behavior Therapy for Insomnia (CBT-I)

Conditions studied

Insomnia — all drugs for Insomnia →
Cardiovascular Risk Factor — all drugs for Cardiovascular Risk Factor →

Sponsor

Walter Reed National Military Medical Center

Who can join

18 and older, any sex, with Insomnia or Cardiovascular Risk Factor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigates the feasibility, acceptability, and effectiveness of adding Cognitive-Behavioral Therapy for Insomnia (CBT-I) to the standard care received at the Integrative Cardiac Health Project (ICHP) on insomnia symptoms and severity. ICHP is an established cardiovascular disease prevention program to reduce cardiovascular disease risk through the adoption of lifestyle changes related to improvements in diet, stress, sleep, and exercise. The study will be conducted among patients with insomnia who are already enrolled in the ICHP cardiovascular risk prevention program. This is a single-center study, prospective, randomized, controlled, interventional trial within ICHP at the Walter Reed National Military Medical Center (WRNMMC). To conduct both phases of the study, up to 76 total male and female patients enrolled in ICHP who meet criteria for insomnia will be recruited. Participants who meet inclusion and exclusion criteria for this study, and consent to participate, will be randomized to one of two conditions: (1) ICHP, or (2) ICHP + CBT-I treatment. CBT-I treatment will consist of four in-person appointments and two telephone appointments.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Insomnia

Currently open trials in the same condition.

NCT07384429 — Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease · Phase 4 · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting
NCT07071324 — CF Wellness Program · NA · recruiting
NCT07417813 — A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders · recruiting
NCT06348082 — Project Women's Insomnia Sleep Health Equity Study (WISHES) · NA · recruiting

Other Walter Reed National Military Medical Center trials

Trials by the same sponsor.

NCT07151417 — Use of Corticosteroid in Intraopertive Injections in Total Knee Replacement Surgery. · Phase 2, PHASE3 · not yet recruiting
NCT06636136 — Transtibial Osseointegration · NA · recruiting
NCT06808347 — Difference in Serum Estrogen Level Based on Methods of Vaginal Estrogen Application (fingertip Vs Applicator Use) in Pos · Phase 4 · not yet recruiting
NCT06731348 — Patient Satisfaction With Opioid Restriction After Urogynecologic Surgery · Phase 4 · enrolling by invitation
NCT06729151 — Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patient · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02779023 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Walter Reed National Military Medical Center
Last refreshed: 11 September 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02779023.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing